Title: Chi-Ling Tseng: Innovator in Biotech
Introduction
Chi-Ling Tseng is an accomplished inventor based in Shanghai, China. He is currently associated with Shanghai Henlius Biotech Inc. Despite having no granted patents to his name, his contributions to the field of biotechnology are noteworthy. He works alongside talented colleagues such as Weidong Jiang and Pei-Hua Lin.
Latest Patent Applications
Chi-Ling Tseng has been involved in several significant patent applications. One of his latest applications is titled "Anti-MSLN Antibodies and Methods of Use." This disclosure relates to antibodies and antibody derivatives that bind to MSLN, along with methods of utilizing these antibodies. In certain embodiments, the disclosed antibody or antibody derivative comprises a single domain antibody that binds to MSLN. Another notable application is "Anti-GARP/TGF-Beta Antibodies and Methods of Use." This application provides antibodies and antibody derivatives that bind to GARP (also known as LRRC32 and CPPRDD) and/or the GARP/TGFβ complex, along with methods of using these antibodies. In specific embodiments, an anti-GARP/TGFβ antibody or antibody derivative can inhibit a TGFβ signal pathway in a target cell.
Conclusion
Chi-Ling Tseng is a promising inventor in the biotechnology sector, contributing to innovative research and applications. His work has the potential to impact various therapeutic areas significantly.